1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition
(
- Contribution to journal › Article
- 2020
-
Mark
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
(
- Contribution to journal › Article
- 2019
-
Mark
Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells
(
- Contribution to journal › Article
- 2007
-
Mark
Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation
(
- Contribution to journal › Article
- 2001
-
Mark
Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells
(
- Contribution to journal › Article
- 1992
-
Mark
Familial occurrence of hematologic malignancies and other diseases in multiple myeloma : a case-control study
(
- Contribution to journal › Article